Chloromycetin Ophthalmic Drug Interactions
Currently displaying 116 drugs known to have a moderate interaction with Chloromycetin Ophthalmic (chloramphenicol ophthalmic).
- 1 major drug interaction
- 116 moderate drug interactions
Moderate interactions with Chloromycetin Ophthalmic (chloramphenicol ophthalmic)
Note: Showing generic names only.
A
B
- belantamab mafodotin
- belinostat
- bendamustine
- bevacizumab
- bleomycin
- blinatumomab
- brexucabtagene autoleucel
- busulfan
C
D
- dacarbazine
- dactinomycin
- daratumumab
- daunorubicin
- daunorubicin liposomal
- decitabine
- doxorubicin
- doxorubicin liposomal
E
F
G
H
I
- ibritumomab
- idarubicin
- idecabtagene vicleucel
- ifosfamide
- imatinib
- inotuzumab ozogamicin
- interferon alfa-2a
- interferon alfa-2b
- interferon alfa-n1
- interferon alfacon-1
- interferon gamma-1b
- iobenguane I 131
- iodine i 131 tositumomab
- isatuximab
L
- lenalidomide
- levamisole
- linezolid
- lisocabtagene maraleucel
- lomustine
- loncastuximab tesirine
- lurbinectedin
- lutetium lu 177 dotatate
- lutetium lu 177 vipivotide tetraxetan
M
- mechlorethamine
- melphalan
- melphalan flufenamide
- mephenytoin
- mercaptopurine
- methotrexate
- mitomycin
- mitoxantrone
- mogamulizumab
- momelotinib
- mosunetuzumab
N
O
P
- peginterferon alfa-2a
- peginterferon alfa-2b
- pemetrexed
- pentostatin
- phenytoin
- plicamycin
- pralatrexate
- procarbazine
- promazine
Q
R
S
T
- tafasitamab
- talazoparib
- talquetamab
- teclistamab
- temozolomide
- thioguanine
- thiotepa
- tisagenlecleucel
- topotecan
- tositumomab
- trastuzumab
- trimetrexate
U
V
Z
Chloromycetin Ophthalmic disease interactions
There is 1 disease interaction with Chloromycetin Ophthalmic (chloramphenicol ophthalmic) which include:
More about Chloromycetin Ophthalmic (chloramphenicol ophthalmic)
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.